This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> BioMarin Pharmaceutical (BMRN) upgraded to Outperform from Perform at Oppenheimer; tgt raised to $110
> Cullen/Frost (CFR) upgraded to In-line from Underperform at Evercore ISI; tgt raised to $160
Downgrades:
> ABB Ltd (ABB) downgraded to Buy from Conviction Buy at Goldman
> Advanced Micro (AMD) downgraded to Market Perform from Outperform at Northland Capital; tgt lowered to $60
> Ameris Bancorp (ABCB) downgraded to Mkt Perform from Outperform at Raymond James
> Aon (AON) downgraded to Underperform from Mkt Perform at Raymond James
Others:
> Ares Commercial Real Estate (ACRE) resumed with a Buy at BofA Securities; tgt $13
> Business First Bancshares (BFST) initiated with an Outperform at Raymond James; tgt $28
The image featured at the top of this post is ©seb_ra / iStock via Getty Images.